FOXP1: a potential therapeutic target in cancer.

Expert Opin Ther Targets

Division of Hematology/Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, MA, USA.

Published: July 2007

Forkhead Box P1 (FOXP1) is a member of the FOX family of transcription factors which have a broad range of functions. Foxp1 is widely expressed and has been shown to have a role in cardiac, lung and lymphocyte development. FOXP1 is targeted by recurrent chromosome translocations and its overexpression confers a poor prognosis in a number of types of lymphomas, suggesting it may function as an oncogene. In contrast, FOXP1 localises to a tumour suppressor locus at 3p14.1 and loss of FOXP1 expression in breast cancer is associated with a worse outcome, suggesting FOXP1 may function as a tumour suppressor in other tissue types. These data suggest that FOXP1 may not only be useful in prognosis but also may be used to develop FOXP1-directed therapeutic strategies.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4282158PMC
http://dx.doi.org/10.1517/14728222.11.7.955DOI Listing

Publication Analysis

Top Keywords

foxp1
8
tumour suppressor
8
foxp1 potential
4
potential therapeutic
4
therapeutic target
4
target cancer
4
cancer forkhead
4
forkhead box
4
box foxp1
4
foxp1 member
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!